Edmonds Duncan Registered Investment Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,415
Closed -$253K 141
2023
Q4
$253K Buy
3,415
+121
+4% +$7.93K 0.07% 114
2023
Q3
$225K Sell
3,294
-168
-5% -$14.3K 0.06% 122
2023
Q2
$325K Buy
3,462
+110
+3% +$8.58K 0.1% 92
2023
Q1
$227K Buy
+3,352
New +$215K 0.07% 119

Other funds holding EXAS

Edmonds Duncan Registered Investment Advisors's EXAS Position: Q1 2024 in Review

Edmonds Duncan Registered Investment Advisors sold out of Exact Sciences (EXAS) in Q1 2024, closing a stake of 3,415 shares — an estimated $253K sold.

Edmonds Duncan Registered Investment Advisors first reported a position in EXAS in Q1 2023 and held it in 4 quarters. The position peaked at $325K in Q2 2023. 627 funds tracked by Wall St. Rank hold EXAS as of Q1 2024.

  • Edmonds Duncan Registered Investment Advisors reported no remaining Exact Sciences position as of Q1 2024 after selling out during the quarter.
  • Edmonds Duncan Registered Investment Advisors sold 3,415 Exact Sciences shares in Q1 2024, an estimated $253K.
  • Edmonds Duncan Registered Investment Advisors first reported a position in Exact Sciences in Q1 2023 and held it in 4 quarters.
  • Edmonds Duncan Registered Investment Advisors's Exact Sciences position peaked at $325K in Q2 2023.
  • 627 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2024.

Based on Edmonds Duncan Registered Investment Advisors's 13F filing for Q1 2024, filed 18 Apr 2024.